Primary Cilia and Malignant Transformation

原发纤毛与恶性转化

基本信息

  • 批准号:
    8487699
  • 负责人:
  • 金额:
    $ 17.29万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-04-01 至 2015-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Our goal is to explore novel tumor suppressor mechanisms dependent on the integrity of primary cilia. Our preliminary data shows the absence of cilia in cholangiocarcinoma cells; therefore, ciliary dysfunction may be associated with cancer development. The mechanisms leading to ciliary reduction in these tumor cells as well as the consequences of such a lost remain unknown. We HYPOTHESIZE that the functional integrity of cholangiocyte primary cilia is required for the transduction of environmental stimuli, and generates intracellular signals that function as tumor suppressors. We propose that in cholangiocarcinoma, (i) decreased microRNAs expression (i.e. mir-433, mir-22, mir-141, mir-200) leads to overexpression of HDAC6, a cytoplasmic deacetylase that induces ciliary resorption, and the subsequent reduction of cholangiocyte primary cilia; and (ii) ciliary loss generates the disengagement between the environment and the cell interior resulting in derepression of tumorigenic factors and cancer development. In Specific Aim #1 we will characterize the effect of ciliary loss on the normal cholangiocyte phenotype. Our working hypothesis, based upon preliminary data, is that primary cilia and the intracellular signals induced by their multisensory functions are constraining Hedgehog and MAPK pathways, which are involved in cancer development. In Specific Aim #2 we will characterize the effect of specific miRNAs downregulated in CCA on cholangiocyte ciliary expression. Our working hypothesis is that the downregulation of mir-433, mir-22, mir-141, and/or mir-200 in CCA induces the overexpression of HDAC6 and the resorption of cilia. Finally, in Specific Aim #3 we will evaluate the effect of cilia restoration on tumor cells. Our working hypothesis is that this intervention isa potential approach for decreasing cell growth and dedifferentiation of cholangiocarcinoma cells. The results of the present proposal will provide novel information regarding the ciliary-dependent mechanisms controlling the proliferation of tumor cells; and will provide the foundation for a plausible anti-cancer therapeutic treatment based on the rescue of primary cilia architecture and function.
描述(由申请人提供):我们的目标是探索依赖于初级纤毛完整性的新型肿瘤抑制机制。我们的初步数据显示胆管癌细胞中不存在纤毛;因此,纤毛功能障碍可能与癌症的发展有关。导致这些肿瘤细胞纤毛减少的机制以及这种损失的后果仍然未知。我们假设胆管细胞初级纤毛的功能完整性是环境刺激转导所必需的,并产生充当肿瘤抑制因子的细胞内信号。我们提出,在胆管癌中,(i) microRNA 表达(即 mir-433、mir-22、mir-141、mir-200)减少导致 HDAC6 过度表达,HDAC6 是一种细胞质脱乙酰酶,可诱导纤毛吸收,并随后导致胆管细胞初级纤毛减少; (ii)纤毛损失导致环境和细胞内部之间的脱离,从而导致致瘤因子的抑制和癌症的发展。在具体目标#1 中,我们将描述纤毛缺失对正常胆管细胞表型的影响。基于初步数据,我们的工作假设是初级纤毛及其多感觉功能诱导的细胞内信号限制了参与癌症发展的 Hedgehog 和 MAPK 通路。在特定目标#2 中,我们将描述 CCA 中下调的特定 miRNA 对胆管细胞纤毛表达的影响。我们的工作假设是,CCA 中 mir-433、mir-22、mir-141 和/或 mir-200 的下调会诱导 HDAC6 的过度表达和纤毛的吸收。最后,在具体目标#3中,我们将评估纤毛恢复对肿瘤细胞的影响。我们的工作假设是,这种干预是减少胆管癌细胞生长和去分化的潜在方法。本提案的结果将提供有关控制肿瘤细胞增殖的纤毛依赖性机制的新信息;并将为基于挽救初级纤毛结构和功能的合理抗癌治疗奠定基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sergio A Gradilone其他文献

Sergio A Gradilone的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sergio A Gradilone', 18)}}的其他基金

Primary cilia loss in bile duct cells- the interplay with the autophagy machinery
胆管细胞中初级纤毛的损失——与自噬机制的相互作用
  • 批准号:
    10605658
  • 财政年份:
    2023
  • 资助金额:
    $ 17.29万
  • 项目类别:
Primary cilia loss in bile duct cells- the interplay with the autophagy machinery
胆管细胞初级纤毛损失——与自噬机制的相互作用
  • 批准号:
    10898187
  • 财政年份:
    2023
  • 资助金额:
    $ 17.29万
  • 项目类别:
The Cholangiocyte Primary Cilium as a Tumor Suppressor Organelle
胆管细胞初级纤毛作为肿瘤抑制细胞器
  • 批准号:
    9093744
  • 财政年份:
    2015
  • 资助金额:
    $ 17.29万
  • 项目类别:
The Cholangiocyte Primary Cilium as a Tumor Suppressor Organelle
胆管细胞初级纤毛作为肿瘤抑制细胞器
  • 批准号:
    8881519
  • 财政年份:
    2015
  • 资助金额:
    $ 17.29万
  • 项目类别:
Primary Cilia and Malignant Transformation
原发纤毛与恶性转化
  • 批准号:
    8642151
  • 财政年份:
    2013
  • 资助金额:
    $ 17.29万
  • 项目类别:
Primary Cilia and Malignant Transformation
原发纤毛与恶性转化
  • 批准号:
    8976926
  • 财政年份:
    2013
  • 资助金额:
    $ 17.29万
  • 项目类别:
Intracellular calcium in the treatment of polycystic kidney and liver diseases
细胞内钙治疗多囊肾和肝病
  • 批准号:
    7737679
  • 财政年份:
    2009
  • 资助金额:
    $ 17.29万
  • 项目类别:
Intracellular calcium in the treatment of polycystic kidney and liver diseases
细胞内钙治疗多囊肾和肝病
  • 批准号:
    7915676
  • 财政年份:
    2009
  • 资助金额:
    $ 17.29万
  • 项目类别:

相似海外基金

A Phase 2 biomarker driven, Study of DB107, a Retroviral Replicating Vector, Combined With 5-FC in Patients with Recurrent Glioblastoma or Anaplastic Astrocytoma
由生物标志物驱动的 DB107(一种逆转录病毒复制载体)与 5-FC 联合治疗复发性胶质母细胞瘤或间变性星形细胞瘤患者的 2 期研究
  • 批准号:
    10722246
  • 财政年份:
    2023
  • 资助金额:
    $ 17.29万
  • 项目类别:
Multimodality Neuroimaging Evaluation of Cognitive Functioning in Lower Grade Astrocytoma
低级别星形细胞瘤认知功能的多模态神经影像评估
  • 批准号:
    10701775
  • 财政年份:
    2022
  • 资助金额:
    $ 17.29万
  • 项目类别:
Targeting metabolic vulnerabilities in Astrocytoma, IDH-mutant, Grade 4
针对星形细胞瘤、IDH 突变、4 级的代谢脆弱性
  • 批准号:
    10306229
  • 财政年份:
    2021
  • 资助金额:
    $ 17.29万
  • 项目类别:
Targeting metabolic vulnerabilities in Astrocytoma, IDH-mutant, Grade 4
针对星形细胞瘤、IDH 突变、4 级的代谢脆弱性
  • 批准号:
    10491830
  • 财政年份:
    2021
  • 资助金额:
    $ 17.29万
  • 项目类别:
metabolome analysis focusing on the malignant transformation of astrocytoma
关注星形细胞瘤恶性转化的代谢组分析
  • 批准号:
    19K09520
  • 财政年份:
    2019
  • 资助金额:
    $ 17.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Exploring the tumorigenesis of H3F3A mutations in pediatric high-grade astrocytoma (HGA) and Giant cell tumor of the bone (GCTB).
探索儿童高级星形细胞瘤 (HGA) 和骨巨细胞瘤 (GCTB) 中 H3F3A 突变的肿瘤发生。
  • 批准号:
    377032
  • 财政年份:
    2017
  • 资助金额:
    $ 17.29万
  • 项目类别:
    Fellowship Programs
A Phase 1 Study of M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma.
M032(一种表达 IL-12 的基因工程 HSV-1)在复发/进行性多形性胶质母细胞瘤、间变性星形细胞瘤或胶质肉瘤患者中的 1 期研究。
  • 批准号:
    9455636
  • 财政年份:
    2017
  • 资助金额:
    $ 17.29万
  • 项目类别:
Defining the role of the histone 3 (H3.3G34R) mutation in the pathogenesis of pediatric high grade astrocytoma
定义组蛋白 3 (H3.3G34R) 突变在儿童高级星形细胞瘤发病机制中的作用
  • 批准号:
    368929
  • 财政年份:
    2017
  • 资助金额:
    $ 17.29万
  • 项目类别:
    Operating Grants
Establishment of diffuse astrocytoma cell line utilizing advanced culture system
利用先进的培养系统建立弥漫性星形细胞瘤细胞系
  • 批准号:
    16K15641
  • 财政年份:
    2016
  • 资助金额:
    $ 17.29万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Detection and clinical application of pilocytic astrocytoma minimal residual disease
毛细胞型星形细胞瘤微小残留病的检测及临床应用
  • 批准号:
    16K10011
  • 财政年份:
    2016
  • 资助金额:
    $ 17.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了